Executive interview – Kazia Therapeutics

Executive interview – Kazia Therapeutics

Kazia Therapeutics — 9 videos in collection

More on this equity

In this video, Kazia’s CEO, Dr James Garner, explains the background to this interesting product which has a novel brain penetrating action which potentially could give it a unique role in the chronic treatment of glioblastoma. He discusses the latest trial data and the further development of the product in 2020.

You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free